Rigel Pharmaceuticals Inc (RIGL)
25.04
+0.73
(+3.00%)
USD |
NASDAQ |
Nov 21, 16:00
25.11
+0.07
(+0.28%)
After-Hours: 20:00
Rigel Pharmaceuticals Market Cap: 441.08M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 441.08M |
| November 20, 2024 | 428.22M |
| November 19, 2024 | 421.17M |
| November 18, 2024 | 400.57M |
| November 15, 2024 | 424.52M |
| November 14, 2024 | 483.71M |
| November 13, 2024 | 482.83M |
| November 12, 2024 | 479.48M |
| November 11, 2024 | 439.49M |
| November 08, 2024 | 388.76M |
| November 07, 2024 | 271.98M |
| November 06, 2024 | 265.63M |
| November 05, 2024 | 255.42M |
| November 04, 2024 | 247.84M |
| November 01, 2024 | 250.10M |
| October 31, 2024 | 240.07M |
| October 30, 2024 | 251.34M |
| October 29, 2024 | 252.57M |
| October 28, 2024 | 255.74M |
| October 25, 2024 | 249.40M |
| October 24, 2024 | 254.16M |
| October 23, 2024 | 256.97M |
| October 22, 2024 | 261.73M |
| October 21, 2024 | 260.85M |
| October 18, 2024 | 266.13M |
| Date | Value |
|---|---|
| October 17, 2024 | 266.66M |
| October 16, 2024 | 275.29M |
| October 15, 2024 | 269.48M |
| October 14, 2024 | 266.31M |
| October 11, 2024 | 271.77M |
| October 10, 2024 | 268.25M |
| October 09, 2024 | 266.13M |
| October 08, 2024 | 276.52M |
| October 07, 2024 | 271.06M |
| October 04, 2024 | 282.51M |
| October 03, 2024 | 282.69M |
| October 02, 2024 | 292.20M |
| October 01, 2024 | 288.32M |
| September 30, 2024 | 284.98M |
| September 27, 2024 | 288.91M |
| September 26, 2024 | 281.52M |
| September 25, 2024 | 282.40M |
| September 24, 2024 | 287.68M |
| September 23, 2024 | 240.35M |
| September 20, 2024 | 242.11M |
| September 19, 2024 | 240.88M |
| September 18, 2024 | 239.82M |
| September 17, 2024 | 240.70M |
| September 16, 2024 | 241.93M |
| September 13, 2024 | 241.05M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
115.77M
Minimum
Jun 10 2022
835.45M
Maximum
Feb 08 2021
356.52M
Average
297.12M
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 3.508M |
| Palatin Technologies Inc | 18.35M |
| iBio Inc | 22.42M |
| Theriva Biologics Inc | 3.562M |
| Oragenics Inc | 3.305M |
Market Cap Related Metrics
| PE Ratio | 109.17 |
| PS Ratio | 2.797 |
| Price to Free Cash Flow | 42.52 |
| Price | 25.04 |
| Earnings Yield | 0.92% |
| Operating PE Ratio | 46.34 |
| Normalized PE Ratio | 109.17 |